| pubmed-article:16397035 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C0205281 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C2349179 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:16397035 | lifeskim:mentions | umls-concept:C1518527 | lld:lifeskim |
| pubmed-article:16397035 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16397035 | pubmed:dateCreated | 2006-1-6 | lld:pubmed |
| pubmed-article:16397035 | pubmed:abstractText | In clinical cancer trials for evaluating neoadjuvant chemotherapy, tumor downstaging is frequently used as a surrogate end point for overall survival. We evaluated the surrogacy of tumor downstaging using data from a follow-up observational study in bladder cancer. | lld:pubmed |
| pubmed-article:16397035 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16397035 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16397035 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16397035 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16397035 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:16397035 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16397035 | pubmed:author | pubmed-author:OgawaOsamuO | lld:pubmed |
| pubmed-article:16397035 | pubmed:author | pubmed-author:NishiyamaHiro... | lld:pubmed |
| pubmed-article:16397035 | pubmed:author | pubmed-author:TeramukaiSato... | lld:pubmed |
| pubmed-article:16397035 | pubmed:author | pubmed-author:MatsuiYoshiyu... | lld:pubmed |
| pubmed-article:16397035 | pubmed:author | pubmed-author:FukushimaMasa... | lld:pubmed |
| pubmed-article:16397035 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16397035 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16397035 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:16397035 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16397035 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16397035 | pubmed:pagination | 139-43 | lld:pubmed |
| pubmed-article:16397035 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:meshHeading | pubmed-meshheading:16397035... | lld:pubmed |
| pubmed-article:16397035 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16397035 | pubmed:articleTitle | Evaluation for surrogacy of end points by using data from observational studies: tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer. | lld:pubmed |
| pubmed-article:16397035 | pubmed:affiliation | Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan. steramu@kuhp.kyoto-u.ac.jp | lld:pubmed |
| pubmed-article:16397035 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16397035 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16397035 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16397035 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16397035 | lld:pubmed |
